Quick answer
This page lists 80 immunotherapy doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Immunotherapy doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Immunotherapy doctors
FeaturedDr. Vinod Raina
MBBS, MD (Internal Medicine), DM (Medical Oncology), Fellowship, Fellowship
Chairman – Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India40+ Years experience
Why consider this doctor?
- 40+ years of experience in Medical Oncologist
- Chairman – Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
- Professor and Head of Medical Oncology, AIIMS, New Delhi (2001 – 2013)
Expertise & Procedures
- High-Dose Chemotherapy with Stem Cell Rescue
- Autologous Bone Marrow Transplant
- Chemotherapy (Induction, Consolidation, Maintenance)
- Concurrent Chemoradiotherapy
- Palliative Chemotherapy
Medical Oncologist Experience: 40+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Pooja Babbar
MBBS, MD Radiation Oncology, Senior Residency, DM Medical Oncology – Gold Medalist, European Certification in Medical Oncology (ESMO), Diploma in Medico Legal System, MBA in Hospital Management
Consultant & Unit Head – Medical Oncology · Specialty: Medical Oncologist
Fortis Hospital Manesar Gurugram, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant & Unit Head – Medical Oncology, Fortis Hospital, Manesar, Gurugram (Present)
- American Oncology Institute, Gurugram
Expertise & Procedures
- Chemotherapy (Adjuvant, Neoadjuvant, Palliative)
- Immunotherapy (Checkpoint Inhibitors)
- Targeted Therapy (HER2, EGFR, VEGF, CDK4/6 inhibitors)
- Hormonal Therapy (Breast, Prostate cancer)
- Oncological Emergency Management
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Hospital ManesarHospital accreditation: NABH, NABL, JCI
Dr. Ashok Kumar Vaid
MBBS, MD (General Medicine), DM (Medical Oncology)
Chairman — Medical Oncology, Hematology & Stem Cell Transplant · Specialty: Medical Oncologist & BMT Specialist
Medanta - The Medicity Gurgaon, India44+ Years experience
Why consider this doctor?
- 44+ years of experience in Medical Oncologist & BMT Specialist
- Chairman — Medical Oncology, Hematology & Stem Cell Transplant, Medanta – The Medicity, Gurgaon (Present)
- Pioneered one of the largest stem cell transplant programmes in private-sector north India
Expertise & Procedures
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Bone Marrow Aspiration & Biopsy
- Chemotherapy Administration
Medical Oncologist & BMT Specialist Experience: 44+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Imran Khan
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India10+ Years experience
Why consider this doctor?
- 10+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Associate Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Targeted Therapy Infusions
- Immunotherapy Infusions
- PICC Line Insertion
- Bone Marrow Aspiration & Biopsy
Medical Oncologist Experience: 10+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Huma Noor
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy Infusions
- Targeted & Hormonal Therapy
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Paediatric & Adult)
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
(Lt Gen) Dr. C. S. Narayanan, VSM
MBBS, MD (Medicine), DM (Neurology)
Chairman — Manipal Institute of Neuro Sciences · Specialty: Neurologist
Manipal Hospital Dwarka New Delhi, India35+ Years experience
Why consider this doctor?
- 35+ years of experience in Neurologist
- Chairman, Manipal Institute of Neuro Sciences, Manipal Hospital Dwarka, New Delhi — Present
- Consultant Neurologist, Manipal Hospital Dwarka, New Delhi — Present
Expertise & Procedures
- Video EEG Monitoring and Analysis
- Intravenous Thrombolysis (tPA) for Acute Stroke
- Mechanical Thrombectomy for Large Vessel Occlusion
- Nerve Conduction Velocity (NCV) and EMG Studies
- Comprehensive Movement Disorder Assessment and Management
Neurologist Experience: 35+ YearsHospital Affiliation: Manipal Hospital DwarkaHospital accreditation: NABH, NABL
Dr. Dipanjan Panda
MBBS, MD (General Medicine), DM (Medical Oncology)
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Indraprastha Apollo Hospitals New Delhi, India15+ Years experience
Why consider this doctor?
- 15+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Indraprastha Apollo Hospitals, New Delhi (Present)
- Associate Professor & HOD — Medical Oncology, Institute of Liver and Biliary Sciences (ILBS), New Delhi
Expertise & Procedures
- Systemic chemotherapy for solid tumours
- Targeted therapy regimens
- Immunotherapy (checkpoint inhibitors)
- Oral chemotherapy management
- Adjuvant and neo-adjuvant cancer treatment planning
Medical Oncologist Experience: 15+ YearsHospital Affiliation: Indraprastha Apollo Hospitals
Dr. Sai Lakshmi Daayana
MBBS, MS, MRCOG
Consultant — Obstetrics, Gynecology & Gynecologic Oncology · Specialty: Gynecologic Oncosurgeon
Apollo Hospital Jubilee Hills Hyderabad, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Gynecologic Oncosurgeon
- Consultant — Obstetrics, Gynecology & Gynecologic Oncology, Apollo Hospital Jubilee Hills, Hyderabad, India
- Clinical Lecturer in Surgical Gynaecological Oncology, Christie Hospital, Manchester, United Kingdom
Expertise & Procedures
- Radical hysterectomy with pelvic lymphadenectomy
- Sentinel lymph node biopsy in gynecologic cancer
- Cytoreductive surgery for advanced ovarian cancer
- Cervical cancer surgical management and reconstruction
- Vulvar cancer wide local excision and inguinal lymphadenectomy
Gynecologic Oncosurgeon Experience: 22+ YearsHospital Affiliation: Apollo Hospital Jubilee HillsHospital accreditation: JCI, NABH
Dr. M. Janarthinakani
MBBS, MD
Senior Consultant — Radiation Oncology · Specialty: Radiation Oncologist
Rela Hospital Chennai, India25+ Years experience
Why consider this doctor?
- 25+ years of experience in Radiation Oncologist
- Senior Consultant, Radiation Oncology — Rela Hospital, Chennai
- Consultant and Educator — Cancer Institute (WIA), Adyar, Chennai
Expertise & Procedures
- Image-Guided Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Brachytherapy for Cervical and Rectal Cancers
- 3D Conformal Radiation Therapy
- Intensity-Modulated Radiation Therapy Planning
Radiation Oncologist Experience: 25+ YearsHospital Affiliation: Rela HospitalHospital accreditation: NABH, NABL
Dr. Sapna Manocha Verma
MBBS, MD in Radiotherapy
Senior Consultant — Radiation Oncology · Specialty: Radiation Oncologist
Indraprastha Apollo Hospital Delhi NCR, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Radiation Oncologist
- Senior Consultant — Radiation Oncology, Indraprastha Apollo Hospital, Delhi NCR, Present
- Extensive clinical practice across major cancer centers in India with 22+ years of dedicated experience in radiation oncology and multimodal cancer management
Expertise & Procedures
- Stereotactic Body Radiation Therapy (SBRT)
- Stereotactic Radiosurgery
- Brachytherapy
- 3D Conformal Radiation Therapy
- Intensity-Modulated Radiation Therapy (IMRT)
Radiation Oncologist Experience: 22+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Hospitals where these doctors practise
🇮🇳 Manesar, Gurgaon, IndiaStarting from$1,000
Fortis Hospital Manesar
Est. 2013
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditationJCI — Joint Commission International accreditation
ImmunotherapyCardiac SurgeryOrthopedicsBariatric Surgery
1+
Doctors for Immunotherapy
4.4
74 reviews
350+
Beds
13+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$1,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
10+
Doctors for Immunotherapy
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
2+
Doctors for Immunotherapy
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
Manipal Hospitals Dwarka
Est. 2017
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ImmunotherapyCardiologyOncologyOrthopedics
1+
Doctors for Immunotherapy
4.4
54 reviews
380+
Beds
9+
Years Since Founded
🇮🇳 Hyderabad, IndiaStarting from$1,000
Apollo Hospitals, Jubilee Hills
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
5+
Doctors for Immunotherapy
4.1
44 reviews
550+
Beds
38+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Dr. Rela Institute and Medical Centre
Est. 2018
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Immunotherapy
4.7
108 reviews
450+
Beds
8+
Years Since Founded
🇮🇳 Chennai, IndiaStarting from$1,000
Apollo Hospitals, Greams Road
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
5+
Doctors for Immunotherapy
4.7
125 reviews
560+
Beds
43+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$1,000
BLK-Max Super Speciality Hospital
Est. 1959
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
ImmunotherapyCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Immunotherapy
3.8
48 reviews
650+
Beds
67+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for head & neck cancer treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Immunotherapy?
Immunotherapy uses drugs that help the patient's own immune system recognize and destroy cancer cells, and is used across many cancers including breast, lung, colorectal, gastric/esophageal, liver/pancreatic, ovarian/gynaecological, head & neck cancers, leukemia, lymphoma, and multiple myeloma. It is given as an infusion in cycles, either alone or combined with chemotherapy/targeted therapy, and India offers globally approved immunotherapy drugs and advanced options like CAR-T cell therapy at a fraction of Western costs. Treatment plans are individualized based on tumor type, biomarker status (e.g., PD-L1, MSI), and stage of disease.
Who may be considered?
Immunotherapy may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Drugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
3 approaches available for this procedure:
Immune Checkpoint Inhibitor Therapy
Most CommonDrugs such as PD-1/PD-L1 and CTLA-4 inhibitors are given as IV infusions every 2-4 weeks to block signals that let cancer cells evade the immune system, often combined with chemotherapy for greater effect.
Comprehensive Investigations
Estimated cost: $400 - $1,500
CBC, liver and kidney function tests, thyroid function tests, PD-L1/MSI/biomarker testing, contrast CT/PET-CT, ECG, tumor board review
Treatment / Procedure Estimate
Estimated cost in India: $1,500 - $3,500 per cycle
Stay in India
Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~1 day (day-care per cycle)
Recovery period (outside hospital): ~2-3 days recommended between cycles
Total stay: approx 4-6 cycles over 3-6 months
Usually Included in Hospital Package
- Oncologist consultations
- Day-care infusion facility
- Drug administration and monitoring
- Pre-cycle blood work
- Nursing care during infusion
Usually Not Included
- Cost of immunotherapy drug (billed per cycle)
- Interim PET-CT/imaging for response assessment
- Management of immune-related side effects if hospitalization needed
- Genetic/biomarker testing not covered under package
Recovery and follow-up
Most patients tolerate immunotherapy infusions as outpatients and can resume light activity within a day or two, though fatigue, skin rash, or flu-like symptoms are common and are monitored through regular blood tests before each cycle. CAR-T patients require a longer inpatient recovery period with close monitoring for delayed immune reactions.
Risks
Immunotherapy can trigger immune-related side effects affecting the skin, gut, lungs, liver, or endocrine glands, and rarely severe reactions like cytokine release syndrome (especially with CAR-T) that require prompt hospital management. Response to treatment varies by tumor type and biomarker status, and not all patients achieve remission.
Alternatives
Depending on the cancer type and stage, alternatives include conventional chemotherapy, targeted therapy, radiation therapy, hormonal therapy, surgery, or a combination approach as advised by the tumor board.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Histopathology and biopsy report confirming cancer type
- Biomarker/genetic testing results (PD-L1, HER2, MSI, EGFR, etc.)
- Recent CT/PET-CT/MRI imaging reports
- Complete blood count and liver/kidney function tests
- Previous chemotherapy/radiotherapy/surgery records
- Bone marrow biopsy report (for blood cancers)
- Cardiac evaluation report (ECG/ECHO)
- Discharge summaries from previous hospitalizations
Patient information needed
- Current age, weight, and general performance status
- Detailed cancer diagnosis with stage and biomarker status
- History of prior treatments and response to them
- Any known drug allergies or autoimmune conditions
- Current medications including steroids or immunosuppressants
- Presence of other chronic conditions (diabetes, heart or lung disease)
- Availability of a caregiver/attendant during treatment
- Preferred treatment start date and travel flexibility
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Immunotherapy) and procedure (Immunotherapy) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Immunotherapy in India
What is Head & Neck Cancer?
Head and neck cancer refers to a diverse group of malignant tumours arising from the mucosal surfaces, glands, or other tissues of the head and neck region, most commonly squamous cell carcinomas of the oral cavity, pharynx, or larynx. The term encompasses several distinct cancer types that differ in location, behaviour, and treatment approach.
What are the symptoms and health risks of Head & Neck Cancer?
Common warning signs include a persistent sore throat or hoarseness, a non-healing mouth ulcer or red/white patch, difficulty or pain when swallowing, a lump in the neck, unexplained ear pain, nasal obstruction, or unintentional weight loss. Symptoms may vary considerably depending on the tumour's site—for example, voice changes are more typical of laryngeal involvement, while a painless neck mass may suggest lymph node spread from an oropharyngeal primary. It is important to note that these symptoms can also be caused by non-cancerous conditions, so the presence of any one of them does not establish a diagnosis and must be evaluated by a qualified clinician.
How is Head & Neck Cancer diagnosed?
Diagnosis typically begins with a detailed history and thorough head and neck examination, including flexible nasopharyngoscopy or laryngoscopy to visualise mucosal surfaces directly. A tissue biopsy—obtained endoscopically, via fine-needle aspiration of a neck mass, or through open biopsy—is essential for histological confirmation and to determine tumour type and grade. Staging is then established using cross-sectional imaging (CT and/or MRI of the head, neck, and chest), and in many cases PET-CT scanning, following the AJCC TNM classification system (stages I–IV), with HPV/p16 status increasingly tested for oropharyngeal tumours because it significantly influences prognosis and treatment planning.
How is Head & Neck Cancer treated?
The appropriate treatment strategy depends on tumour site, histological type, TNM stage, HPV status, and the patient's overall health, and is best determined through a multidisciplinary tumour board involving oncology, surgery, and radiation specialists. Early-stage cancers (stages I–II) may be managed with a single modality—either surgery or radiotherapy—while locally advanced disease (stages III–IV) typically requires combined approaches such as concurrent chemoradiotherapy, with or without surgery. For eligible patients, systemic therapies including chemotherapy, immunotherapy (e.g., checkpoint inhibitors such as pembrolizumab), and targeted therapy (e.g., cetuximab) play important roles, particularly in the recurrent or metastatic setting; the optimal regimen is always individualised based on clinical assessment.
Can Head & Neck Cancer be treated without a procedure?
Non-surgical pathways are well-established and widely used in head and neck cancer management. Definitive (curative-intent) chemoradiotherapy is a standard of care for many oropharyngeal, laryngeal, and hypopharyngeal cancers, and can preserve organ function while achieving disease control comparable to surgery in appropriately selected patients. Systemic agents—chemotherapy, immunotherapy, and targeted therapy—are central to treatment of recurrent or metastatic disease, and surveillance-only management may be appropriate in select, very early low-risk lesions after discussion with a specialist.
When is Immunotherapy considered for Head & Neck Cancer?
Immunotherapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Head & Neck Cancer?
Head and neck cancers are managed by a multidisciplinary team typically led or co-led by a head and neck surgical oncologist (or otolaryngologist–head and neck surgeon), a radiation oncologist, and a medical oncologist with expertise in head and neck malignancies. Additional input from speech and language therapists, dietitians, and reconstructive surgeons is often integral to comprehensive care.
How do I choose a doctor for Head & Neck Cancer?
When selecting a care team, look for specialists who practice within a dedicated head and neck oncology multidisciplinary unit, with documented experience in your specific tumour site, access to advanced endoscopic and robotic surgical platforms or intensity-modulated radiotherapy (IMRT) where relevant, and a clear pathway for rehabilitation, nutritional support, and long-term follow-up. Asking about the team's annual case volume for your tumour type and their approach to HPV testing and tumour board review can help you compare providers meaningfully.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.